<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02545166</url>
  </required_header>
  <id_info>
    <org_study_id>CI163115</org_study_id>
    <nct_id>NCT02545166</nct_id>
  </id_info>
  <brief_title>Validation of a Purine Biosensor in Detecting Acute Cerebral Ischaemia: Carotid Endarterectomy Model in SMARTChip</brief_title>
  <acronym>CEMS</acronym>
  <official_title>Validation of a Purine Biosensor in Detecting Acute Cerebral Ischaemia: Carotid Endarterectomy Model in SMARTChip</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospitals Coventry and Warwickshire NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospitals of North Midlands NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospitals Coventry and Warwickshire NHS Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will validate the sensitivity of a purine biosensor (SMARTChip) in detecting acute&#xD;
      cerebral ischaemia in a group of patients undergoing elective carotid endarterectomy. The&#xD;
      study will also investigate whether blood purine levels are indicative of future risk of&#xD;
      stroke by comparing pre-operative blood purine levels in carotid endarterectomy patients&#xD;
      (high risk group) and blood purine levels in a group of age and sex-matched controls.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Blood purine levels have been shown to be associated with ischaemic brain conditions. Studies&#xD;
      have consistently shown that levels of purines in the blood rise rapidly when oxygen flow to&#xD;
      the brain is reduced (hypoxia) and returns to the pre-hypoxic level within 30 minutes upon&#xD;
      restoring the oxygen supply. There is therefore the potential for blood purine levels to be&#xD;
      used to diagnose strokes more quickly. The investigators have undertaken a programme of work&#xD;
      to develop, test and refine a purine biosensor, called SMARTChip. This is a prospective&#xD;
      observational study to test the sensitivity of SMARTChip in detecting fluctuations in blood&#xD;
      purine levels throughout various stages of carotid endarterectomy. Carotid endarterectomy&#xD;
      patients have been chosen for this study because the procedure provides a controlled normoxic&#xD;
      and hypoxic brain environment without compromising patient safety and has clear and&#xD;
      systematic technical steps which will ensure reliable and robust data. The investigators will&#xD;
      test the pre-, peri- and post-operative blood purine levels in 40 patients undergoing carotid&#xD;
      endarterectomy at University Hospitals Coventry and Warwickshire NHS Trust, University&#xD;
      Hospitals of North Midlands NHS Trust and University Hospitals Birmingham NHS Foundation&#xD;
      Trust.&#xD;
&#xD;
      In this study the investigators will also test the hypothesis that purine levels may be&#xD;
      predictive of future stroke risk. In a previous study carried out by the trial team patients&#xD;
      undergoing carotid endarterectomy, a group that is by definition at increased risk of stroke,&#xD;
      were found to have significantly higher purine levels than would be expected in a healthy&#xD;
      population. Therefore a case-control study, including 80 patients recruited from the day&#xD;
      surgery schedules at the three hospitals as controls and the 40 CEA patients recruited for&#xD;
      the observational study as cases, will be undertaken alongside the observational study to&#xD;
      assess whether purine levels differ systematically in CEA patients and controls.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pre-, peri-, and post-operative arterial serum purine concentration (uM)</measure>
    <time_frame>24 hours</time_frame>
    <description>Change in arterial serum purine concentration measured pre-, peri-, and post-operatively in CEA patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pre-, and post-operative arterial serum purine concentration (uM)</measure>
    <time_frame>Baseline</time_frame>
    <description>Arterial serum purine concentration measured pre-operatively in CEA patients, controls and local sampling patients.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pre-, and post-operative capillary serum purine concentration (uM)</measure>
    <time_frame>Baseline</time_frame>
    <description>Pre-operative capillary serum purine concentration in CEA patients, controls and local sampling patients.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Local or general anaesthetic</measure>
    <time_frame>Baseline</time_frame>
    <description>Local or general anaesthetic used during procedure in CEA patients, controls and local sampling patients.</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">195</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Carotid endarterectomy patients</arm_group_label>
    <description>40 male and female patients, aged 18 years and over, scheduled for carotid endarterectomy. Fasted pre-operative (arterial and capillary), peri-operative (arterial) and 1-hour and 24-hour post-operative (arterial) blood samples will be collected and analysed for serum purine concentration.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control patients</arm_group_label>
    <description>80 age and sex-matched control patients scheduled for non-vascular, non-oncological day surgery. A single pre-operative fasted capillary (finger-prick) blood sample will be collected and analysed for serum purine concentration.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dynamic controls</arm_group_label>
    <description>10 aortic aneurysm repair patients, 10 critical leg ischaemia patients, 10 endovascular aneurysm repair patients, 10 kidney transplant patients, and 10 free flap surgery patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local sampling patients</arm_group_label>
    <description>10 Patients undergoing revascularisation, 10 patients undergoing lower limb surgery with a tourniquet and 5 patients diagnosed with acute compartment syndrome.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        40 male or female patients, aged 18 years or over, scheduled for carotid endarterectomy and&#xD;
        80 age and sex-matched control patients scheduled for day surgery. 50 dynamic controls. 25&#xD;
        Local sampling patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        CEA Patients:&#xD;
&#xD;
          -  Aged 18 years and over&#xD;
&#xD;
          -  Scheduled for carotid endarterectomy&#xD;
&#xD;
        Controls&#xD;
&#xD;
          -  Aged 18 years and over&#xD;
&#xD;
          -  Scheduled for day surgery&#xD;
&#xD;
        Dynamic controls&#xD;
&#xD;
          -  Aged 18 years and over&#xD;
&#xD;
          -  Scheduled for open aortic aneurysm repair, critical ischaemic leg surgery (this&#xD;
             includes: Femoral endarterectomy, Axillo-Femoral Bypass Graft, Femoral distal bypass,&#xD;
             Fem-Fem crossover graft, Axillary bifemoral graft, Aortobifemoral graft, and Femoral&#xD;
             popliteal bypass), endovascular aneurysm repair, Kidney transplants, or Free flap&#xD;
             surgery.&#xD;
&#xD;
        Local sampling&#xD;
&#xD;
          -  Aged 18 and over&#xD;
&#xD;
          -  Scheduled for elective lower limb vascular revascularisation, elective lower limb&#xD;
             orthopaedic surgery with a tourniquet or diagnosed with acute compartment syndrome&#xD;
             requiring a fasciotomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        CEA patients:&#xD;
&#xD;
        - Unable/unwilling to provide informed consent&#xD;
&#xD;
        Controls:&#xD;
&#xD;
          -  Unable/unwilling to provide informed consent&#xD;
&#xD;
          -  History of cerebral ischaemia&#xD;
&#xD;
          -  History of cancer&#xD;
&#xD;
          -  History of cardiovascular disease&#xD;
&#xD;
          -  Unable/unwilling to provide a fasting blood sample&#xD;
&#xD;
        Dynamic controls&#xD;
&#xD;
          -  Unable/unwilling to provide informed consent&#xD;
&#xD;
          -  History of cerebral ischaemia&#xD;
&#xD;
          -  History of cancer (except for Free flap surgery patients)&#xD;
&#xD;
        Local sampling&#xD;
&#xD;
          -  Unable/unwilling to provide informed consent&#xD;
&#xD;
          -  History of cerebral ischaemia&#xD;
&#xD;
          -  History of cancer&#xD;
&#xD;
          -  History of cardiovascular disease&#xD;
&#xD;
          -  Unable/unwilling to provide a blood sample&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher HE Imray, MB BS PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospitals Coventry and Warwickshire NHS Trust</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jack Fairhead, BM BCh BA</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospitals of North Midlands NHS Trust</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christopher HE Imray, MB BS PhD</last_name>
    <phone>00442476965222</phone>
    <phone_ext>25222</phone_ext>
    <email>christopher.imray@uhcw.nhs.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Katie M Bruce, MSc</last_name>
    <phone>02476966907</phone>
    <phone_ext>26907</phone_ext>
    <email>katie.bruce@uhcw.nhs.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospitals of North Midlands</name>
      <address>
        <city>Stoke-on-Trent</city>
        <state>Staffordshire</state>
        <zip>ST4 6QG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jack Fairhead, BM BCh BA</last_name>
      <phone>00441782 679884</phone>
      <email>jfairhead@doctors.org.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospitals Coventry and Warwickshire</name>
      <address>
        <city>Coventry</city>
        <state>West Midlands</state>
        <zip>CV2 2DX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher HE Imray, MB BS PhD</last_name>
      <phone>02476965222</phone>
      <phone_ext>65222</phone_ext>
      <email>christopher.imray@uhcw.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Katie M Bruce, MSc</last_name>
      <phone>00442476966907</phone>
      <phone_ext>26907</phone_ext>
      <email>katie.bruce@uhcw.nhs.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Christopher HE Imray, MB BS PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>September 7, 2015</study_first_submitted>
  <study_first_submitted_qc>September 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2015</study_first_posted>
  <last_update_submitted>November 20, 2020</last_update_submitted>
  <last_update_submitted_qc>November 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Purines</keyword>
  <keyword>SMARTChip</keyword>
  <keyword>Ischaemia</keyword>
  <keyword>Carotid endarterectomy</keyword>
  <keyword>Biosensor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Ischemia</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

